Centre Hospitalier Universitaire de Bordeaux

General

Total Cases2
Active Cases2
Patents7
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
07/18/24
SO ORDERED, re 10 Motion for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston of Panitch Schwarze Belisario & Nadel LLP to represent Plaintiffs filed by Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Pharmaceuticals, Inc. Ordered by Judge Jennifer L. Hall on 7/18/2024. (ceg) (Entered: 07/18/2024)
07/17/24
SUMMONS Returned Executed by Pierre Fabre Medicament SAS, Pierre Fabre Pharmaceuticals, Inc., Centre Hospitalier Universitaire de Bordeaux, Universite de Bordeaux.Rubicon Research Private Limited served on 7/15/2024, answer due 8/5/2024. (Jones, Keith) (Entered: 07/17/2024)
07/17/24
Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb) (Entered: 07/17/2024)
07/15/24
Pro Hac Vice Fee - Credit Card Payment received for Philip L. Hirschhorn and Erin M. Dunston. ( re 10 MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston of Panitch Schwarze Belisario & Nadel LLP to represent Plaintiffs )( Payment of $ 100, receipt number ADEDC-4450747).(Jones, Keith) (Entered: 07/15/2024)
07/15/24
MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston of Panitch Schwarze Belisario & Nadel LLP to represent Plaintiffs - filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Medicament SAS, Pierre Fabre Pharmaceuticals, Inc., Universit de Bordeaux. (Attachments: # 1 Certification (Philip L. Hirschhorn), # 2 Certification (Erin M. Dunston))(Jones, Keith) (Entered: 07/15/2024)
07/12/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent New Ways to Care Pharma for Pierre Fabre Pharmaceuticals, Inc. filed by Pierre Fabre Pharmaceuticals, Inc.. (Simmons, John) (Entered: 07/12/2024)
07/12/24
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 07/12/2024)
07/12/24
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Universit de Bordeaux. (Simmons, John) (Entered: 07/12/2024)
07/12/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pierre Fabre SA for Pierre Fabre Medicament SAS filed by Pierre Fabre Medicament SAS. (Simmons, John) (Entered: 07/12/2024)
07/12/24
Summonses Issued (please complete the top portion of the form and print out for use/service). (oam) (Entered: 07/12/2024)